1. The addition of bevacizumab to oxaliplatin, fluorouracil, and leucovorin improves survival duration for patients with previously treated metastatic colorectal cancer.…
Slide 1 Slide 2 “Bread & Butter” Issues in Endoscopy The New England Team Alain Ades, MD Steven Brandwein, MD Pamela Connors, MD Mark Lena, MD Jeffry Potash, MD Gary…
Slide 1 Systemic Approach to Advanced Colon Cancer Mohamed Abdulla (M.D.) Ass. Prof. Clinical Oncology Kasr El-Aini School of Medicine Cairo University April, 2005 Slide…
Slide 1 Colorectal Cancer Slide 2 Worldwide, colon and rectum cancer is the third most common cancer and it is the most common GI cancer. adenocarcinomas The vast majority…
Management of the end stage lung cancer patients: What would the politics be on the intensive care support? Dr Zuhal Karakurt Süreyyapaşa Chest Diseases and Thoracic Surgery…
Aiming at the Wrong Target? Discussion of Abstracts CRA3507 (Alberts) and 3508 (Goldberg) Louis M. Weiner, MD Lombardi Comprehensive Cancer Center Georgetown University Medical…
No Slide Title DEBATE: What is the Optimal Strategy for Liver Only Metastatic Colon Cancer? Michael A. Choti, MD Department of Surgery UT Southwestern Medical Center Great…
Aiming at the Wrong Target? Discussion of Abstracts CRA3507 (Alberts) and 3508 (Goldberg) Louis M. Weiner, MD Lombardi Comprehensive Cancer Center Georgetown University Medical…